Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zoviramin
- Development stage
- Unknown
- Lead developer
- Amin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zoviramin is an oral suspension formulation of the synthetic purine nucleoside analogue acyclovir, developed and marketed by Amin Pharmaceutical. It is indicated for the treatment of herpes simplex virus infections (including cold sores), varicella-zoster virus infections (such as chickenpox and shingles), the prevention of recurrent herpes simplex, and prophylaxis in immunocompromised patients. Acyclovir is selectively converted to its active triphosphate form by viral thymidine kinase and cellular kinases. Acyclovir triphosphate then acts as a competitive inhibitor of viral DNA polymerase and is incorporated into the growing viral DNA chain, leading to premature chain termination and inhibition of viral replication.
- Brand names
- Zoviramin
- Other names
- سوسپانسیون زوویرامینزوویرامین
02
Targets
Herpesvirus DNA polymeraseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))DNA polymerase familyTK2 (Thymidine kinase 2)
Beyond the preview
Go deeper on Zoviramin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zoviramin.